Browsed by
Month: December 2021

IonQ Leads Charge for Quantum Commercialization at Q2B 2021

IonQ Leads Charge for Quantum Commercialization at Q2B 2021

COLLEGE PARK, Md., December 07, 2021–(BUSINESS WIRE)–IonQ, Inc. (“IonQ”) (NYSE: IONQ), a leader in trapped-ion quantum computing, today announced its participation at the fifth Q2B Practical Quantum Computing Conference (Q2B 2021). On the heels of multiple recent milestones, the IonQ team will discuss strategies and tactics for a successful enterprise partnership approach, as well as practical machine learning applications as the team paves the way for quantum computing commercialization. ...  Read more

The Maryland Stem Cell Research Fund (MSCRF) Grant Programs Now Accepting Applications

The Maryland Stem Cell Research Fund (MSCRF) Grant Programs Now Accepting Applications

The Maryland Stem Cell Research Fund (MSCRF) offers six grant programs to accelerate human stem cell-based research, commercialization, and cures. The six programs are designed to support scientists at universities/research institutes or companies based in MD as well as any US-based company with a clinical trial site in MD. ...  Read more

Vaccitech reports promising interim efficacy analysis in Phase 1b/2a clinical study in chronic HBV

Vaccitech reports promising interim efficacy analysis in Phase 1b/2a clinical study in chronic HBV

Interim data from 27 patients, who had completed 3 months in the HBV002 study in chronic Hepatitis B (CHB) patients, demonstrated noted changes in surface antigen (HBsAg) levels, especially in the group receiving low-dose nivolumab with the heterologous boost (VTP-300). ...  Read more